Home / Research Library / ECCO Guidelines on Therapeutics in Ulcerative Coli...
🧬 Medicine & Biology OpenAlex

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

📅 October 8, 2021 👤 Tim Raine, Stefanos Bonovas, Johan Burisch et al. 📖 Journal of Crohn s and Colitis 📊 1,010 citations

🤖 Plain-English Summary

Ulcerative colitis [UC] is a chronic inflammatory bowel disease [IBD] characterised by colonic inflammation extending to a variable extent from the rectum. These definitions of disease extent are recognised as somewhat arbitrary; in clinical practice, topically administered therapies are often used for UC whose extent is limited to the rectum and a portion of the sigmoid colon [proctosigmoiditis], with the term ‘distal colitis’ used to describe this disease distribution.

🔑 Key Findings

  • Care of the patient with UC requires appropriate input from across the multiprofessional team.
  • These guidelines summarise the recommended medical treatment for adults with UC.
  • Other ECCO guidelines consider the approach to UC diagnosis and monitoring, nursing care, management of disease complications, risk of infection, and technical aspects of surgery.

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via OpenAlex.

View on DOI ↗

📋 Article Details

Category 🧬 Medicine & Biology
Published Oct 08, 2021
Journal Journal of Crohn s and Colitis
Authors Tim Raine, Stefanos Bonovas, Johan Burisch, Torsten Kucharzik, Michel Adamina
DOI 10.1093/ecco-jcc/jjab178
Citations 1,010
Source OpenAlex

More 🧬 Medicine & Biology Research